Recent Developments in Antimalarial Drug Discovery

ISSN: 2211-3533 (Online)
ISSN: 2211-3525 (Print)

Volume 14, 2 Issues, 2016

Download PDF Flyer

Anti-Infective Agents

Formerly: Anti-Infective Agents in Medicinal Chemistry

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Recent Developments in Antimalarial Drug Discovery

Anti-Infective Agents, 5(1): 105-122.

Author(s): A. A. Joshi and C L Viswanathan.

Affiliation: Department of Pharmaceutical Chemistry, Bombay College of Pharmacy, Kalina, Santacruz (East),Mumbai-400 098, India.


Malaria with 1 million deaths and about 500 million new cases reported annually is a challenge to drug therapy and discovery. Drug resistance accompanied by lack of progress in the development of vaccines or resistant reversal agents has further aggravated the situation. In this scenario, development of antimalarials acting by novel pathways is the best option. Decoding of the Plasmodium falciparum genome has helped scientists working in the area of drug development by providing new drug targets such as carbonic anhydrase, homocysteine hydrolase, antioxidant proteins, glutathione reductase etc. Efforts are ongoing to elucidate structures and functions of novel targets. These developments will form an important part of this review. Developments related to novel antimalarials such as Ugi adducts of chloroquine, polar derivatives of artemisinins, amino acid complexes of 8-aminoquinolines, bioimidazoles, t-butylperoxyamines etc will also be reviewed. We are working on drug discovery leading to development of novel antimalarials. A basic nucleus pyrimido-[4,5- b]quinoline was developed based on pharmacophoric studies. Appropriate substitutions on this basic nucleus taking into consideration overall basicity and lipophilicity are the prime considerations in the development of novel antimalarials. Preliminary work led to synthesis, characterization and evaluation of nine novel derivatives for antimalarial activity in mice infected with P. berghei using chloroquine as standard. Five out of nine derivatives were active and among these, three derivatives were found to be more potent than chloroquine. Encouraged by this positive outcome, additional novel derivatives are being developed. Efforts are also on to establish the likely targets with which these novel molecules interact.


Malaria, resistance, malarial vaccine, P falciparum genome, targets, antimalarials, pyrimidoquinolines.

Download Free Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 5
Issue Number: 1
First Page: 105
Last Page: 122
Page Count: 18
DOI: 10.2174/187152106774755626
Superbugs USA

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science